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A major question in systems neuroscience is how a single population of neurons
can interact with the rest of the brain to orchestrate complex behavioral states.
The hypothalamus contains many such discrete neuronal populations that individually
regulate arousal, feeding, and drinking. For example, hypothalamic neurons that express
hypocretin (Hcrt) neuropeptides can sense homeostatic and metabolic factors affecting
wakefulness and orchestrate organismal arousal. Neurons that express agouti-related
protein (AgRP) can sense the metabolic needs of the body and orchestrate a state
of hunger. The organum vasculosum of the lamina terminalis (OVLT) can detect the
hypertonicity of blood and orchestrate a state of thirst. Each hypothalamic population
is sufficient to generate complicated behavioral states through the combined efforts
of distinct efferent projections. The principal challenge to understanding these brain
systems is therefore to determine the individual roles of each downstream projection for
each behavioral state. In recent years, the development and application of temporally
precise, genetically encoded tools has greatly improved our understanding of the
structure and function of these neural systems. This review will survey recent advances
in our understanding of how these individual hypothalamic populations can orchestrate
complicated behavioral states due to the combined efforts of individual downstream
projections.
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To ensure that an animal obtains an optimal amount of sleep, food, and water, the brain
must sense the internal environment and influence behavior by producing sensations we
describe as ‘‘tired/awake, ‘‘hungry/full, and ‘‘thirsty/quenched.’’ Amazingly, these complicated
behavioral states are often controlled by discrete populations of neurons, some composed of
only 1000–2000 individual cells. The hypothalamus contains many such populations including
hypocretin (Hcrt—also called ‘‘orexin’’)-expressing neurons in the lateral hypothalamus
that regulate wakefulness and arousal (Alexandre et al., 2013), agouti-related peptide
(AgRP)-expressing neurons in the arcuate nucleus that regulate hunger (Liu et al., 2013),
and organum vasculosum of the lamina terminalis (OVLT) neurons in the preoptic area that
regulate thirst (Bourque, 2008). Each is able to sense signals from the internal environment
and influence animal behavior through diffuse projections throughout the brain.
A term often used to describe the actions of these neuronal populations is
‘‘orchestrate’’—the implication being that these neurons mobilize and unify the actions of several
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discrete players to achieve an outcome that is more than
the sum of its parts. Just as a musical conductor directs an
orchestra to produce a recognizable piece of music, neural
activity in these discrete populations of neurons orchestrates
recognizable behavioral phenotypes. For example, stimulation
of Hcrt neurons produces an increase in wakefulness, while
stimulation of AgRP neurons produces an immediate increase
in food-seeking behavior. The exciting scientific challenge
ahead is to determine exactly how these neurons orchestrate
such deliberate, complicated behavioral states by dissecting the
functional contributions of their downstream projections.
When investigating the functional roles of various
downstream projections from a population of neurons, what
phenotypes should we hypothesize to observe? Surely, some
individual projections may reproduce fundamental aspects of
the overall behavior, while others may produce phenotypes that
the investigator may not even initially consider examining. For
example, neural populations that orchestrate global wake states
may also engage circuitry involved in stress. Populations that
orchestrate hunger may also engage circuitry that suppresses
growth and fertility. Populations that orchestrate thirst may
also engage circuitry that regulates sodium appetite. A thorough
investigation of how these neural populations influence complex
behavioral states must consider several distinct elements that
each contributes to a grander, global phenotype.
These considerations are particularly important given the
recent development and application of genetically encoded
neuronal actuators that have allowed for the unprecedented
study of discrete neuronal populations and their downstream
projections. Optogenetic technology has allowed scientists the
ability to stimulate or inhibit genetically-defined populations
of neurons with millisecond-precise temporal resolution
(Yizhar et al., 2011). Pharmacogenetic technology, such as
the ‘‘Designer Receptors Exclusively Activated by Designer
Drugs’’—DREADDS, allows for the ability to hijack a neuron’s
G-protein signaling cascade to induce or suppress neural activity
(Armbruster et al., 2007). Importantly, these technologies
not only allow for the manipulation of neural activity at the
soma, but also in distal axonal projections (Fenno et al., 2011;
Stachniak et al., 2014). Thus, these technologies have allowed for
the remarkable opportunity to investigate the contribution of
each downstream projection in an overall behavioral phenotype.
Below, we consider the functional dissection of downstream
projections for Hcrt neurons in arousal, AgRP neurons in
hunger, and OVLT neurons in thirst. For each population of
neurons, we provide a brief history of the study of these neurons
and highlight the potential downstream circuit elements that
amalgamate to cause a complex behavioral state.
Hcrt Neurons Orchestrate Wakefulness
and Arousal
Defining Wakefulness and Arousal
Wakefulness is defined as a conscious state in which an animal
can perceive and interact with its environment. This behavioral
state is distinct from sleep, which is defined as a rapidly reversible
state of immobility and greatly reduced sensory responsiveness
to environmental stimuli (Siegel, 2008). In mammals, sleep
is generally divided into slow wave sleep (SWS, or NREM
sleep) and rapid eye movement (REM) sleep. Wakefulness,
SWS, and REM sleep can be quantitatively defined by precise
electroencephalographic (EEG) and electromyographic (EMG)
features.
Although these states of sleep and wake are qualitatively
and quantitatively easy to characterize, it is surprisingly difficult
to define what is meant by ‘‘arousal.’’ This term usually
describes the degree of vigilance during wakefulness, manifested
by an increased length of wake bouts, locomotor activity,
stress hormone activity, cardiovascular activity, thermogenesis,
respiration, and tendency to engage in behaviors such as
sexual interactions, eating, and drug seeking. Simultaneously,
heightened arousal usually results in decreased symptoms of
depression, sensitivity to pain, and the release of growth
hormone.
The Hypocretin System
Although multiple populations of neurons in the brain are
thought to regulate wakefulness and arousal, much research has
focused on a population of neurons in the lateral hypothalamus
that express Hcrt neuropeptides (Hcrt neurons; Saper et al.,
2001, 2005; Sutcliffe and de Lecea, 2002; Sakurai, 2007; Carter
et al., 2009b). The Hcrts consist of a pair of two neuropeptides,
Hypocretin-1 and Hypocretin-2 (Hcrt1 and Hcrt2; also known
as Orexin A and Orexin B, respectively) that are processed
from the same genetic precursor, ‘‘preprohypocretin’’ (de Lecea
et al., 1998; Sakurai et al., 1998). In the brain, these peptides
are expressed exclusively in the perifornical lateral hypothalamus
(de Lecea et al., 1998; Sakurai et al., 1998). Hcrt neurons
are glutamatergic and cause excitatory effects on postsynaptic
targets (de Lecea et al., 1998; van den Pol et al., 1998; Date
et al., 1999; Rosin et al., 2003). Interestingly, these neurons
express other neuromodulators, such as dynorphin (Chou
et al., 2001). Hcrt neurons are completely distinct from an
intermingled population of neurons in the lateral hypothalamus
that express melanin-concentrating hormone (MCH; Broberger
et al., 1998a).
Hcrt neurons receive afferent projections from many
nuclei throughout the brain including from neurons that
are glutamatergic and GABAergic (Henny and Jones, 2006).
Consistent with their known role in promoting wakefulness, Hcrt
neurons are excited by neurotransmitters that promote arousal
including ATP (Wollmann et al., 2005), corticotropin releasing
factor (Winsky-Sommerer et al., 2004), thyrotropin releasing
hormone (Hara et al., 2009), noradrenaline (Bayer et al., 2005),
and acetylcholine (Bayer et al., 2005; Henny and Jones, 2006).
Importantly, sleep-promoting molecules inhibit Hcrt neurons
including GABA and adenosine (Thakkar et al., 2002; Liu and
Gao, 2007).
In turn, Hcrt neurons project diffusely throughout the brain.
Intracerebroventricular (i.c.v.) injection of Hcrt neuropeptides
into the brain causes an increase in expression of Fos, an
indirect marker of neural activity, widely throughout the
brain (Date et al., 1999). Hcrt neurons send especially dense
projections to the locus coeruleus (LC), tuberomammilary
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nucleus (TMN), ventral tegmental area (VTA), dorsal raphe
nuclei, other hypothalamic nuclei, and the cortex (Peyron
et al., 1998; Date et al., 1999). The afferent projection patterns
of Hcrt neurons match the expression patterns of the two
hypocretin receptors, Hcrt-r1 and Hcrt-r2 (Trivedi et al., 1998).
Hcrt-r1 binds Hcrt1 with high affinity and binds Hcrt with
100–1000-fold lower affinity; Hcrt-r2 has a high affinity for
both Hcrt1 and Hcrt2 (Sakurai et al., 1998; Lang et al.,
2006).
Neural activity in Hcrt neurons correlates with states of
heightened arousal. Expression of Fos in Hcrt neurons correlates
with wakefulness (Estabrooke et al., 2001) and release of
Hcrt1 is significantly higher during wakefulness compared to
sleep (Kiyashchenko et al., 2002). In vivo recordings in freely
moving animals show that Hcrt neurons fire maximally during
arousal, including behavior accompanied with strong locomotor
activity such as eating, grooming, and exploratory behavior (Lee
et al., 2005; Mileykovskiy et al., 2005). In contrast to their
spontaneous activity in acute brain slices (Eggermann et al.,
2003), Hcrt neurons are relatively silent during periods of low
activity, completely silent during SWS and REM sleep, and are
reactivated during REM sleep-to-wake transitions (Lee et al.,
2005; Mileykovskiy et al., 2005). In fact, bursts of activity in Hcrt
neurons during sleep predict sleep-to-wake transitions (Lee et al.,
2005).
The crucial role of hypocretins in arousal stability stems from
the original finding that impairment of the Hcrt system causes
the sleep disorder narcolepsy in mice (Chemelli et al., 1999;
Hara et al., 2001; Mochizuki et al., 2004), dogs (Lin et al., 1999),
and humans (Nishino et al., 2000; Peyron et al., 2000; Gencik
et al., 2001). Most human narcoleptic patients have decreased
levels of Hcrt in their cerebrospinal fluid (Nishino et al., 2000;
Ripley et al., 2001; Dauvilliers et al., 2003) and postmortem
analysis shows a reduction of Hcrt neurons (Thannickal et al.,
2000) and reduced expression of the Hcrt peptides (Peyron et al.,
2000) in the brain. Interestingly, Hcrt levels are also reduced in
other diseases associated with deficits in wakefulness including
Guillain-Barre syndrome (Ripley et al., 2001; Kanbayashi et al.,
2002) and myotonic dystrophy (Martínez-Rodríguez et al.,
2003), while Hcrt levels are elevated in some patients with
restless leg syndrome (Allen et al., 2002). The Hcrt system is
also necessary for the increase in arousal typically observed
in response to fasting (Yamanaka et al., 2003), as well as
for normal emergence from general anesthesia (Kelz et al.,
2008). Using modern optogenetic techniques, it has been
shown that photoinhibition of Hcrt neurons expressing the
inhibitory chloride pump Halorhodopsin from Natronomonas
(NpHR) induces slow wave sleep (Tsunematsu et al., 2011).
Taken together, these studies demonstrate the necessity of
Hcrt neurons in maintaining and promoting normal states of
wakefulness.
Gain of function studies demonstrate that Hcrt peptides
and Hcrt neurons are sufficient to increase wakefulness. I.c.v.
injection of Hcrt1 increases wakefulness (Piper et al., 2000)
as well as general locomotor behaviors such as burrowing,
grooming, and exploratory activity (Ida et al., 1999; Furlong et al.,
2009). Optogenetic photostimulation of Hcrt neurons expressing
Channelrhodopsin 2 (ChR2) causes sleep-to-wake transitions
throughout the light/dark cycle (Adamantidis et al., 2007; Carter
et al., 2009a). Likewise, pharmacogenetic stimulation of Hcrt
neurons with the artificial (DREADD) stimulatory hM3Dq
receptor increases wakefulness and reduces sleep.
Hcrt Neuron Projections Mediating Wakefulness
How do Hcrt neurons orchestrate wakefulness and arousal?
Hcrt neurons project to many nuclei throughout the brain
known to promote arousal, such as the LC, TMN, VTA and
basal forebrain (Saper et al., 2005). Indeed, Hcrt neuropeptides
cause depolarization of postsynaptic cells and an increase in
wakefulness when selectively microinjected into the LC (Hagan
et al., 1999; Horvath et al., 1999; Ivanov and Aston-Jones, 2000;
Walling et al., 2004), TMN (Bayer et al., 2001; Eriksson et al.,
2001; Huang et al., 2001; Ishizuka et al., 2002; Schöne et al.,
2012), basal forebrain (BF; Eggermann et al., 2001; España
et al., 2001; Thakkar et al., 2001), dorsal raphe nucleus (Brown
et al., 2001, 2002; Liu et al., 2002; Takahashi et al., 2005), VTA
(Nakamura et al., 2000; Korotkova et al., 2003), laterodorsal
tegmental nucleus (Xi et al., 2001; Burlet et al., 2002), preoptic
area (Methippara et al., 2000), and pontine reticular formation
(Brevig et al., 2010). Thus, several downstream brain regions are
sufficient to mediate, at least in part, Hcrt neurons effects on
wakefulness.
Whether any single downstream region is necessary for
Hcrt neurons to promote wakefulness is a matter of debate.
Huang et al. (2001) showed that i.c.v. injection of Hcrt
increases wakefulness, but not in H1R knockout mice that
don’t express receptors for histaminergic signaling. Because
histamine in the brain is selectively produced by neurons
in the TMN, this study raises the possibility that the TMN
is necessary for Hcrt-mediated sleep to wake transitions.
However, optogenetic photostimulation of Hcrt neurons
causes sleep-to-wake transitions in histidine decarboxylase
knockout mice that lack the ability to produce histamine
(Carter et al., 2009a), calling into question the necessity of
histaminergic signaling for Hcrt-mediated wakefulness. In
contrast, in wild type mice, Hcrt-mediated sleep-to-wake
transitions are blocked when the LC is concomitantly inhibited
(Carter et al., 2012). Furthermore, knockdown of the Hcrt-r1
receptor in the LC increases REM sleep (Chen et al., 2010).
Knockdown of the Hcrt-r2 receptor in the pontine reticular
formation also increases REM sleep and can cause behavioral
cataplexy (Thakkar et al., 1999). Additionally, Hcrt-induced
hyperlocomotion and grooming behavior is significantly
reduced following central administration of dopamine receptor
antagonists (Nakamura et al., 2000), suggesting the necessity
of the VTA-dopamine system in mediating Hcrt’s effects of
hyperarousal during wakefulness. Thus, the effect of Hcrt
neurons on wakefulness probably involves more than one
downstream target, with different postsynaptic neurons playing
an important, distinct role.
Informative attempts have been made to rescue muscle
paralysis and normal bouts of wakefulness in mouse models
of narcolepsy by selectively expressing Hcrt peptides or Hcrt
receptors in specific brain regions. Hcrt gene transfer into the
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zona incerta (Liu et al., 2011) or dorsolateral pons (Blanco-
Centurion et al., 2013) of Hcrt knockout mice is sufficient
to reduce cataplexy and improve wake maintenance. In mice
lacking Hcrt receptors, selective re-expression of receptors
in the dorsal raphe nucleus or LC attenuates cataplexy and
fragmentation of wakefulness (Hasegawa et al., 2014).
Hcrt Neuron Projections Mediating
Arousal-Related Behaviors
Beyond simple classifications of sleep and wake, environmental
conditions and stimuli that increase arousal also often engage
the physiological response to stress. Consistently, Hcrt neurons
project to corticotropin releasing factor (CRF) neurons within
the paraventricular nucleus (PVN; Peyron et al., 1998),
neurons that activate the hypothalamus-pituitary-adrenal (HPA)
axis which regulates circulating stress hormones. Centrally
administered Hcrt increases activity in CRF-expressing PVN
neurons (Kuru et al., 2000; Samson et al., 2002; Sakamoto
et al., 2004) and causes a dose-dependent increase in plasma
concentration of adrenocorticotropic hormone (ACTH) and
corticosterone (Jászberényi et al., 2000; Kuru et al., 2000; Al-
Barazanji et al., 2001; Russell et al., 2001; Samson et al., 2002).
Behaviorally, Hcrt neurons may induce anxiety-like behavior
through projections to the bed nucleus of the stria terminalis
(BNST; Lungwitz et al., 2012) and central amygdala (Bisetti
et al., 2006). Taken together, these reports demonstrate the
necessity and sufficiency of Hcrt signaling in the physiological
and behavioral hallmarks of stress, and point to the PVN, BNST,
and amygdala as critical sites of action.
Hcrt neurons have also been shown to engage physiological
aspects of a heightened arousal state. Central injection of Hcrt
peptides causes an increase in heart rate and mean arterial
pressure (Samson et al., 1999; Shirasaka et al., 1999; Antunes
et al., 2001; Wang et al., 2001) as does selective microinjection
into the rostroventral lateral medulla (RVLM; Chen et al.,
2000; Machado et al., 2002; Shahid et al., 2012), nucleus of the
solitary tract (NTS; de Oliveira et al., 2003), raphe nuclei (Luong
and Carrive, 2012), and intrathecal cavity of the spinal cord
(Shahid et al., 2011). Ablation of Hcrt receptors or antagonism
of Hcrt receptors reduces basal blood pressure (Kayaba et al.,
2003; Li et al., 2013). Central injection of Hcrts also causes an
increase of oxygen consumption (Wang et al., 2001; Asakawa
et al., 2002; Young et al., 2005), an effect mimicked by selective
microinjection into the preBötzinger or phrenic nuclei (Young
et al., 2005). Finally, central injection of Hcrts causes an increase
in brown adipose tissue thermogenesis and body temperature
(Balaskó et al., 1999; Yoshimichi et al., 2001; Monda et al.,
2007), an effect mediated by the ventromedial hypothalamus
(VMH; Monda et al., 2005), and raphe pallidus (Tupone et al.,
2011). Taken together, these studies not only demonstrate a clear
role for Hcrt neurons in promoting physiological hallmarks of
arousal, but also specific anatomical targets that mediate their
effects.
Hcrt neurons also play a role in food-seeking behavior.
Indeed, the alternate name for Hcrts, orexins, was termed due
to the original finding that i.c.v. infusion of Hcrts increase food
intake (Sakurai et al., 1998). However, this effect is not as potent
as other orexigenic peptides (Edwards et al., 1999; see below for
a description of orexigenic AgRP neurons). Antagonism of Hcrt
receptors enhances behavioral satiety (Rodgers et al., 2001), and
food anticipatory activity is decreased when Hcrt neurons are
genetically ablated (Akiyama et al., 2004). The effects of Hcrt
neurons on food-seeking behavior seem to be mediated by direct
projections to the arcuate nucleus (Burdakov et al., 2003; van den
Top et al., 2004; Ma et al., 2007), a key brain region that regulates
energy homeostasis, as well as the lateral hypothalamus and
paraventricular hypothalamus (PVH; Dube et al., 1999; Sweet
et al., 1999).
A heightened arousal state also often leads to alterations
in reward processing, such as reinstatement of previously
extinguished drug-seeking behavior or increased association
between an environmental cue and drug reward. Interestingly,
Hcrt neurons have been repeatedly shown to play a major role
in cue-induced reinstatement and reward seeking in response to
cocaine (Boutrel et al., 2005; Harris et al., 2005; Borgland et al.,
2006; Harris and Aston-Jones, 2006; Smith et al., 2009, 2010),
ethanol (Shoblock et al., 2011; Srinivasan et al., 2012), nicotine
(Hollander et al., 2008; LeSage et al., 2010; Plaza-Zabala et al.,
2010), morphine (Georgescu et al., 2003; Harris et al., 2005, 2007;
Narita et al., 2006; Sharf et al., 2008, 2010), and heroin (Smith and
Aston-Jones, 2012). These effects are largely mediated by direct
projections to the mesolimbic VTA (Borgland et al., 2006, 2008;
España et al., 2010, 2011; Srinivasan et al., 2012; Taslimi et al.,
2012; Hrabovszky et al., 2013) and nucleus accumbens (Thorpe
and Kotz, 2005; Sharf et al., 2008; Mukai et al., 2009; Mori et al.,
2011), brain structures well known for their roles in regulating
reward processing.
Recently, an interesting debate has emerged about the
potentially dichotomous functions of Hcrts in wakefulness and
reward seeking. Harris and Aston-Jones (2006) suggested that
Hcrt neurons can be functionally subdivided into a medial
group, which regulates wakefulness and stress, and a lateral
group, which regulates reward. This hypothesis was initially
supported by the finding that hypocretin neurons can be
functionally subdivided into at least two populations based
on their electrophysiological properties (Schöne et al., 2011).
However, retrograde tracers injected into either the LC or
VTA do not seem to preferentially label either electrically-
active class of Hcrt neuron, nor do they preferentially label a
medial or lateral population (González et al., 2012). Interestingly,
no study has injected retrograde tracers into two downstream
populations of Hcrt neurons in the same animal, thus, future
studies are needed to resolve whether Hcrt neurons can be
anatomically and functionally subdivided into two or more
populations.
Hcrt neurons also promote hyperarousal during sexual
behavior. Hcrt neurons potentiate male sexual behavior (Di
Sebastiano et al., 2010), and antagonism of Hcrt receptors blocks
copulation (Muschamp et al., 2007) and prevents conditioned
place preference for sexual behavior (Di Sebastiano et al., 2011).
These effects seem to be mediated by direct projections to the
median preoptic area (MPOA; Gulia et al., 2003).
A state of behavioral arousal is not only associated with
increases in activity and physiological parameters, but also an
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active suppression of parameters such as depression, pain, and
growth. Interestingly, Hcrt neurons have been shown to induce
an antidepressive-like effect in rodent models of depression
(Feng et al., 2008), potentially mediated by projections to the
VTA (Nocjar et al., 2012) and hippocampus (Ito et al., 2008). Hcrt
neurons have been repeatedly demonstrated to exert analgesic
and anti-nociceptive properties (Bingham et al., 2001), effects
mediated by direct projections to pain-processing areas such as
the ventrolateral periaqueductal gray (vlPAG; Azhdari Zarmehri
et al., 2011; Ho et al., 2011) and laminae I-II neurons in the
spinal cord (Yamamoto et al., 2002, 2003; Cheng et al., 2003;
Suyama et al., 2004; Kajiyama et al., 2005; Mobarakeh et al.,
2005). Finally, Hcrt neurons suppress the release of growth
hormone releasing hormone (GHRH), and therefore indirectly
the release of plasma growth hormone (Seoane et al., 2004), by
projections to GHRH-expressing cells in the PVH (López et al.,
2004).
Taken together, these studies demonstrate that Hcrt neurons
can orchestrate a behavioral state of wakefulness and various
forms of arousal via widespread projections throughout the
brain (Figure 1). Like examining the contribution of a single
section of an orchestra, investigating the contribution of Hcrts
on any single brain region will not reflect the global sum of
Hcrt activity on heightened states of arousal. An important
question for future research is whether Hcrt neurons can be
anatomically and functionally subdivided into multiple, discrete
subpopulations, each projecting to a distinct downstream region.
Additionally, it will be beneficial to know if different patterns of
neural activity in Hcrt neurons (e.g., different firing frequencies
or temporal patterns of action potentials) selectively recruit
different downstream nuclei due to differential expression of
postsynaptic receptors.
AgRP Neurons Orchestrate Food-Seeking
Behavior
AgRP Neurons and Feeding
The brain regulates food intake by detecting peripheral signals
about nutrient status and energy stores, integrating this
information with cognitive and sensory cues, and producing
appropriate feeding behavior (Schwartz et al., 2000; Abizaid
et al., 2006; Morton et al., 2006). While there are multiple
populations of neurons in the brain that help regulate feeding,
much previous research has focused on orexigenic AgRP
neurons in the hypothalamic arcuate nucleus as being principal
mediators of food seeking behavior. In addition to expressing
AgRP, these neurons also co-express neuropeptide Y (NPY;
Broberger et al., 1998b; Hahn et al., 1998) as well as the
inhibitory neurotransmitter GABA (Tong et al., 2008; Wu
et al., 2009). AgRP neurons are distinct from an intermingled
population of neurons in the arcuate nucleus that express pro-
opiomelanocortin (POMC; Hahn et al., 1998; Wilson et al.,
1999).
AgRP neurons directly sense and respond to circulating
satiety and hunger signals. For example, AgRP neurons express
receptors for leptin, a satiety hormone secreted by fat cells
that causes a decrease in food-seeking behavior (Halaas et al.,
1995; Pelleymounter et al., 1995). In response to leptin, these
neurons downregulate AgRP and NPY mRNA expression and
decrease neuronal activity (Mizuno and Mobbs, 1999; Korner
et al., 2001; van den Top et al., 2004; Baver et al., 2014). In
contrast, AgRP neurons also express receptors for ghrelin, a
hunger-inducing hormone secreted by the stomach (Nakazato
et al., 2001). In response to ghrelin and conditions of fasting,
these neurons upregulate AgRP and NPY mRNA expression
and increase neuronal activity (Kamegai et al., 2000; Nakazato
et al., 2001; Seoane et al., 2003; van den Top et al., 2004;
Takahashi and Cone, 2005; Staszkiewicz et al., 2007; Wang
et al., 2014). Thus, AgRP neurons are primed to detect
peripheral signals from the body and orchestrate a central feeding
response.
Loss of function experiments show that AgRP neurons are
necessary for normal feeding behavior. Genetic ablation of AgRP
neurons results in mice that are hypophagic and lean (Bewick
et al., 2005; Gropp et al., 2005), or even mice that stop eating
altogether (Luquet et al., 2005). Interestingly, genetic ablation of
only the AgRP or NPY peptides (or both in combination) do not
result in a lack of feeding (Qian et al., 2002), suggesting a critical
role for GABA in mediating the downstream effects of AgRP
neurons. Indeed, selective removal of GABA fromAgRP neurons
causes decreased feeding (Tong et al., 2008; Krashes et al., 2013),
an effect that can be rescued by delivering a GABA agonist into
the brain (Wu et al., 2009).
Consistent with loss of function experiments, gain of
function studies show that AgRP neurons are sufficient to
induce feeding. Central injection of the AgRP peptide promotes
feeding (Rossi et al., 1998) and chronic overexpression of
AgRP causes obesity (Graham et al., 1997; Ollmann et al.,
1997). The AgRP peptide directly antagonizes the MC3R and
MC4R melanocortin receptors (Ollmann et al., 1997; Quillan
et al., 1998; Rossi et al., 1998), critical components of the
melanocortin system that promotes satiety and decreases feeding
(Cone, 2005). Recently, genetically-encoded neuromodulation
tools have been used to selectively stimulate AgRP neural
activity in freely-behaving mice. ChR2 mediated-stimulation
of AgRP neurons causes immediate feeding (Aponte et al.,
2011), while hM3Dq-mediated stimulation of AgRP neurons
causes robust feeding over hours and an obesity phenotype
when applied over several days (Krashes et al., 2011).
Taken together, these studies show that AgRP neurons can
selectively orchestrate a specific behavioral state of robust
feeding.
AgRP Neuron Projections that Mediate Feeding
To determine how AgRP neurons orchestrate feeding, previous
studies selectively investigated the effect injecting the AgRP
peptide directly into discrete target regions on food intake.
AgRP neurons project to the PVN, the BNST, the PAG, the
parabrachial nucleus (PBN), the lateral septum (LS), the median
preoptic nucleus (MnPO), the central nucleus of the amygdala
(CeA), the dorsomedial hypothalamic nucleus (DMH), the
ventromedial hypothalamic nucleus (VMH), and the POMC-
expressing neurons in the arcuate nucleus (Broberger et al.,
1998b; Haskell-Luevano et al., 1999; Légrádi and Lechan, 1999;
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FIGURE 1 | (A) Downstream projections from hypocretin (Hcrt) neurons and
their (B) potential functional roles in wakefulness and arousal. Arc, arcuate
nucleus; BF, basal forebrain; BNST; bed nucleus of the stria terminalis; CeA,
central nucleus of the amygdala; DRN, dorsal raphe nuclei; IML,
intermediolateral cell column of the spinal cord; LC, locus coeruleus; LH, lateral
hypothalamus; MPOA, median preoptic area; NAc, nucleus accumbens; NTS,
nucleus of the solitary tract; PreBötz, preBötzinger complex; PVH,
paraventricular hypothalamus; RVLM, rostroventral lateral medulla; TMN,
tuberomammilary nucleus; vlPAG, ventrolateral periaqueductal gray; VMH,
ventromedial hypothalamic nucleus; VTA, ventral tegmental area.
Mihály et al., 2000). Selective injection of the AgRP peptide
into the PVN, DMN, MPO, and CeA increases feeding (Cowley
et al., 1999; Kim et al., 2000; Wirth and Giraudo, 2000;
Boghossian et al., 2010), whereas injections into the arcuate,
lateral hypothalamus, and VMH has no effect (Kim et al., 2000).
However, because AgRP is not the only peptide/transmitter
released by these neurons, these studies do not rule out the
possibility that GABA mediates an increase in feeding in these
areas.
Recently, two laboratories employed different methods to
investigate which downstream projections of AgRP neurons
mediate an increase in food intake. The lab of Richard Palmiter
generated AgRPDTR mice in which the diphtheria toxin receptor
(DTR) is selectively expressed in AgRP neurons, causing
selective ablation of these neurons when mice are injected
with diphtheria toxin. Ablation of AgRP neurons causes a
starvation phenotype (Luquet et al., 2005) and, consistent with
their expression of the inhibitory neurotransmitter GABA, an
increase in Fos expression in downstream targets (Wu et al.,
2008). To determine if increasing inhibition to one or more
of these downstream targets could rescue feeding in these
mice, the GABAA receptor agonist bretazenil was selectively
injected into the LS, PAG, PVH, and PBN. Surprisingly,
bretazenil injection into the PBN (but not other areas) rescued
feeding after AgRP ablation. Subsequent work showed that
the neurons that mediated this effect are located in the
external lateral region of the PBN and specifically express
calcitonin gene related peptide (CGRP; Carter et al., 2013).
Thus, these studies demonstrated that AgRP-mediated inhibition
of CGRP-positive PBN neurons was necessary for feeding to
occur.
The laboratory of Scott Sternson used an optogenetic
approach to determine the effects of selectively stimulating
AgRP neuron axon terminals in downstream brain regions
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on food intake behavior. Stimulating AgRP projections in
the PVN, BNST, lateral hypothalamus, and paraventricular
thalamic nucleus (PVT) resulted in a statistically significant
increase in food intake, whereas stimulating projections
in the PBN, CeA, and PAG had no significant effect
(Atasoy et al., 2012; Betley et al., 2013). Interestingly, using
cell-type specific viral tracing tools, Betley et al. (2013)
found that individual AgRP neurons tend to preferentially
project to individual downstream regions (as opposed to
projecting to two or more areas), demonstrating that AgRP
neurons form multiple, parallel circuits to regulate feeding
behavior.
Obviously, the findings indicating the functional relevance
of AgRP neural projections to the PBN from the Palmiter
group and the findings indicating importance of AgRP neural
projections to the PVN, BNST, lateral hypothalamus (LH), and
PVT, as well as previous AgRP neuropeptide injection studies
that demonstrate functional importance in the CeA and PVN,
need to be reconciled. It is important to note the differences
in methodology between studies: while the Palmiter group
demonstrated the necessity of inhibiting CGRP PBN neurons
for feeding, the Sternson group demonstrated the sufficiency
of other downstream brain regions in causing food intake.
AgRP neurons likely orchestrate food intake through several
mechanisms, stimulating regions that promote the hedonic,
emotional, and craving aspects of hunger, while simultaneously
inhibiting mechanisms of satiety and appetite suppression.
Thus, stimulating AgRP projections to the PBN may not
directly stimulate food intake, but instead may reduce appetite
suppression during conditions of relatively low food intake. This
hypothesis is supported by previous studies showing that central
injection of AgRP overcomes appetite suppression in rodent
models of cancer and conditioned taste aversion (Wirth et al.,
2002; Joppa et al., 2007). Future experiments should stimulate
AgRP neuron projections to the PBN during conditions of
visceral malaise to determine if they are sufficient to overcome
PBN-induced appetite suppression.
AgRP Neuron Projections that Mediate
Non-Feeding Behaviors
During a hungry behavioral state, animals tend to shut down
other physiological processes such as growth, reproduction,
and nociception, while increasing food exploratory activity
and the HPA stress response. Consistently, previous studies
demonstrate that central injection of AgRP neuropeptides inhibit
puberty and sex hormones (Vulliémoz et al., 2005; Sheffer-Babila
et al., 2013), reduce nociception (Bellasio et al., 2003; Bertorelli
et al., 2005), increase locomotion (Dietrich et al., 2012), and
increase plasma stress hormone concentrations (Dhillo et al.,
2002; Xiao et al., 2003). These studies indicate that hunger is
about much more than simply increasing food intake, but also
mediating other behavioral states to ensure that an organism
prioritizes feeding over behaviors that are not immediately
essential for survival (Figure 2). Future studies investigating the
functional roles of AgRP neuron downstream projections should
incorporate behavioral assays in addition to food consumption.
Such studies will add to the valuable contributions of the
Palmiter, Sternson, and other groups, to show how the AgRP
neuron population orchestrates the physiological and behavioral
response to hunger.
The OVLT Orchestrates Water-Seeking
Behavior
OVLT Neurons and Thirst
Like brain arousal systems and food-intake systems, there
is probably no single population of neurons that regulates
drinking behavior. However, much evidence has focused on the
hypothalamic OVLT as a central population of neurons that
orchestrates thirst and the physiological response to dehydration
(Bourque et al., 1994; McKinley et al., 2006; Bourque, 2008).
These neurons are located at the anterior wall of the third
ventricle, a circumventricular organ with a relative relaxation
of the blood brain barrier (McKinley et al., 2003). Thus, these
neurons are in a prime location to sense plasma osmolality,
transduce information about fluid hypertonicity into neural
activity, and orchestrate the behavioral state of thirst.
Multiple studies demonstrate an increase in OVLT neural
activity in response to thirst. OVLT neurons increase expression
of Fos, an indirect marker of neural activity, in response to
dehydration (McKinley et al., 1994; Ji et al., 2005; Gottlieb
et al., 2006; Yoshimura et al., 2013), hypertonic saline (Oldfield
et al., 1991; Kovács and Sawchenko, 1993; Bisley et al., 1996;
Somponpun et al., 2004; Ho et al., 2007; Miller et al., 2013), and
administration of the thirst-generating hormone angiotensin II
(McKinley et al., 1992; Oldfield et al., 1994). Electrophysiological
recordings in vivo and in vitro confirm that the rate of OVLT
firing increases with the concentration of extracellular fluid
osmolality (Sayer et al., 1984; Vivas et al., 1990; Nissen et al., 1993;
Ciura and Bourque, 2006), demonstrating that these neurons can
directly translate hypertonicity into an increase in neural activity.
Complementary studies in humans using functional magnetic
resonance imaging demonstrate an increase in OVLT activity in
response to hypertonic stimuli (Egan et al., 2003; Morita et al.,
2004; Farrell et al., 2011).
Multiple studies also suggest that the OVLT is necessary and
sufficient for water-seeking behavior. Loss-of-function studies
demonstrate that lesions of the OVLT result in significant
deficits in drinking and water-seeking behavior (Buggy and
Jonhson, 1977; McKinley et al., 1982, 1999; Thrasher et al.,
1982; Thrasher and Keil, 1987; Hochstenbach and Ciriello,
1996). Likewise, gain-of-function studies show that injection
of hypertonic saline directly into the OVLT region causes
immediate and reversible water-seeking behavior (Andersson,
1971; Buggy et al., 1979).
OVLT Projections that Mediate Thirst
How does the OVLT orchestrate the response to dehydration
and extracellular hypertonicity? OVLT neurons are known to
project to several brain regions (Camacho and Phillips, 1981;
Farrell et al., 2011), notably the PVN (Larsen and Mikkelsen,
1995; Morita et al., 2004; Shi et al., 2008), the supraoptic nucleus
(SON;Honda et al., 1990; Richard and Bourque, 1992, 1995; Yang
et al., 1994; Armstrong et al., 1996; Bourque and Richard, 2001;
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FIGURE 2 | (A) Downstream projections from AgRP neurons and (B) their potential functional roles in food-seeking behavior. BNST, bed nucleus of the stria
terminalis; CeA, central nucleus of the amygdala; LH, lateral hypothalamus; PAG, periaqueductal gray; PBN, parabrachial nucleus; PVH, paraventricular
hypothalamus; PVT, paraventricular thalamic nucleus.
Morita et al., 2004; Trudel and Bourque, 2010), the insular and
anterior cingulate cortex (Egan et al., 2003; Hollis et al., 2008;
Farrell et al., 2011), the vlPAG (Uschakov et al., 2009), the PBN
(Moga et al., 1990), and the MnPO (Camacho and Phillips,
1981). Each of these regions probably coordinates a distinct
organismal response to conserve and seek water (Figure 3). For
example, magnocellular neurons in the PVN and SON produce
the hormone vasopressin to enhance water reabsorption in the
kidneys. Thus, it is likely that OVLT-to-PVN and OVLT-to-SON
projections mediate the body’s physiological response to water
deficits (Richard and Bourque, 1995; Bourque and Richard, 2001;
Shi et al., 2008; Trudel and Bourque, 2010). Projections to the
insular and anterior cingulate cortices have been suggested to
mediate the conscious perception of thirst (Egan et al., 2003;
Hollis et al., 2008), while the vlPAG may mediate the discomfort
and ‘‘pain’’ resulting from lack of water (Uschakov et al., 2009).
The PBN contains neurons that regulate salt appetite (Geerling
and Loewy, 2007; Geerling et al., 2011), and therefore may
integrate homeostatic information about osmotic balance to
regulate behavioral control of plasma sodium concentration.
Interestingly, the MnPO projects to central regions involved
in thermoregulation (Uschakov et al., 2007; Nakamura and
Morrison, 2008) and arousal (Uschakov et al., 2007), perhaps
indicating how information about osmotic balance may be
integrated into other animal behaviors. Clearly, more work is
necessary to clarify the functional role of these projections and
determine how OVLT neurons orchestrate the behavioral state
of thirst.
Unlike Hcrt and AgRP neurons, the OVLT does not seem
to express a unique genetic marker, hence its name reflects
an anatomical location and not expression of a neuropeptide.
Unfortunately for neuroscientists, this lack of a genetic marker
also presents challenges in the application of spatially precise
experimental tools such as optogenetics, pharmacogenetics, or
even mouse knockout studies. Future studies should attempt
to identify a unique genetic marker for these neurons, as has
been accomplished for specific nuclei in other systems (Sanz
et al., 2009; Knight et al., 2012; Ekstrand et al., 2014). In the
absence of such a marker, perhaps it will be possible to apply
genetically encoded neuromodulation tools using Fos promoter-
based temporal expression vectors (Reijmers et al., 2007) or
projection-based anatomical tools that deliver genes to neurons
based on their axonal projection patterns (Gradinaru et al., 2010).
Such tools would allow for a thorough characterization of OVLT
neurons in osmoregulation and the contribution of each of its
efferent targets.
Conclusion
Clearly, much impressive work over the past two decades has
elucidated the role of Hcrt neurons in wakefulness, AgRP
neurons in food-seeking behavior, and OVLT neurons in
water-seeking behavior. The recent development of genetically
encoded neuromodulation tools has greatly advanced our
understanding of these systems. Because it is currently unknown
if OVLT neurons express a distinct genetic marker, it has been
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FIGURE 3 | (A) Downstream projections from OVLT neurons and (B) their potential functional roles in water-seeking behavior. ACC, anterior cingulate cortex; PBN,
parabrachial nucleus; PVH, paraventricular hypothalamus; SON, supraoptic nucleus; vlPAG, ventrolateral periaqueductal gray.
relatively difficult to target these neurons compared with the
Hcrt and AgRP systems. Nevertheless, the identification of these
systems as neural populations capable of detecting homeostatic
signals from the body and orchestrating behavioral states of
wakefulness, hunger, and thirst, are well established.
So far, most studies applying optogenetic or DREADD
stimulation/inhibition to these neurons have generally employed
behavioral assays that examine their global behavioral states.
For example, most studies of Hcrt neurons have tested the
effects of stimulation/inhibition on EEG/EMG-based parameters
of wakefulness, while most studies of AgRP neurons have
tested effects on total food intake. Given that these neural
populations project diffusely to many brain regions, these
cutting-edge methods can now be used to examine other
aspects of wakefulness and ingestive behaviors, such as stress,
motivation, and organismal physiology.
Recent studies about the role of individual downstream
projections from hypothalamic nuclei that ‘‘orchestrate’’
behavior seem to suggest two lessons for future studies:
(1) If stimulation of a neural projection (i.e., axon terminals
in a downstream region) does not reproduce the effects of
stimulation at the cell soma, such a result does not indicate
that the neural projection doesn’t play a role in the overall
behavior. For example, if stimulating the projections of AgRP
neurons to the PAG or PBN does not produce feeding behavior
(Betley et al., 2013), these projections likely have other vital
functions, such as inhibiting visceral signals of fullness or
satiety. Additionally, (2) the projection patterns of these neural
populations inform our definitions of what it means to be
tired/awake, hungry/full, and thirsty/quenched. For example,
we are conditioned to think of hunger as a state of ‘‘emptiness’’,
analogous to an empty signal on a gas tank. However, a hungry
behavioral state must engage pathways that increase arousal,
motivation, and anxiety while simultaneously suppressing
unnecessary behaviors, such as growth and reproduction.
Current and future studies of Hcrt, AgRP, and OVLT neurons
are exciting because they reveal the complex nature of the
behavioral states of wakefulness, hunger, and thirst, and
prove that these states are truly more than the sum of their
parts.
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